Search research articles
Contact Us
Filters
Showing results (381-390 of 621) with videos related to
Page
of 63
Sort By:
BJS Open
|
February 23, 2022
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study
Osama Moussa, Ricky Harminder Bhogal, George Malietzis, et al.
Journal of the National Cancer Institute
|
October 30, 2012
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
Arnaud D Roth, Mauro Delorenzi, Sabine Tejpar, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 22, 2021
<sup>227</sup>Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study
Ola Lindén, Andrew T Bates, David Cunningham, et al.
The Oncologist
|
May 7, 2017
Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy
Francesco Sclafani, Gina Brown, David Cunningham, et al.
Clinical Pharmacokinetics
|
September 6, 2015
Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies
Elodie Odore, François Lokiec, Esteban Cvitkovic, et al.
World Journal of Nuclear Medicine
|
July 22, 2022
The Diagnostic Accuracy of <sup>18</sup> F-FGD-PET/CT for Cancer of the Gallbladder: A Retrospective Study
Stephanos Pericleous, Sophie L F Doran, Andrew Wotherspoon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 3, 2015
Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial
Francesco Sclafani, Clare Peckitt, David Cunningham, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 28, 2020
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial
Naser Davarzani, Lindsay C Hewitt, Matthew D Hale, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 20, 2005
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer
Ian Chau, Andrew R Norman, David Cunningham, et al.
Clinical Colorectal Cancer
|
November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study
Hamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.
Page
of 63
Search research articles
Search
Showing results (381-390 of 621) with videos related to
Sort By:
Page
of 63
BJS Open
|
February 23, 2022
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study
Osama Moussa, Ricky Harminder Bhogal, George Malietzis, et al.
Journal of the National Cancer Institute
|
October 30, 2012
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
Arnaud D Roth, Mauro Delorenzi, Sabine Tejpar, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 22, 2021
<sup>227</sup>Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human, Phase I Study
Ola Lindén, Andrew T Bates, David Cunningham, et al.
The Oncologist
|
May 7, 2017
Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy
Francesco Sclafani, Gina Brown, David Cunningham, et al.
Clinical Pharmacokinetics
|
September 6, 2015
Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies
Elodie Odore, François Lokiec, Esteban Cvitkovic, et al.
World Journal of Nuclear Medicine
|
July 22, 2022
The Diagnostic Accuracy of <sup>18</sup> F-FGD-PET/CT for Cancer of the Gallbladder: A Retrospective Study
Stephanos Pericleous, Sophie L F Doran, Andrew Wotherspoon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 3, 2015
Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial
Francesco Sclafani, Clare Peckitt, David Cunningham, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
June 28, 2020
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial
Naser Davarzani, Lindsay C Hewitt, Matthew D Hale, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 20, 2005
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer
Ian Chau, Andrew R Norman, David Cunningham, et al.
Clinical Colorectal Cancer
|
November 14, 2017
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study
Hamzeh Kayhanian, Emily Goode, Francesco Sclafani, et al.
Page
of 63